Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Webb

Showing results (21-30 of 96) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|November 4, 2022
Type 2 diabetesEhtasham Ahmad, Soo Lim, Roberta Lamptey, et al.
Plos One|June 5, 2008
Topical oestrogen keratinises the human foreskin and may help prevent HIV infectionAndrew J Pask, Kerry J McInnes, David R Webb, et al.
Diabetes Research and Clinical Practice|September 4, 2019
The right place for Sulphonylureas todayDavid R Webb, Melanie J Davies, Janet Jarvis, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2008
CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-betWeiming Xu, Maria Celeridad, Sabita Sankar, et al.
Diabetologia|May 3, 2018
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificatesFrancesco Zaccardi, Nafeesa N Dhalwani, David R Webb, et al.
British Journal of Hospital Medicine (London, England : 2005)|February 28, 2006
Multi-resistant Escherichia coli sepsis following transrectal ultrasound-guided prostate biopsyAdee-Jonathan Davidson, David R Webb, Nathan Lawrentschuk, et al.
Diabetes, Obesity & Metabolism|May 7, 2020
Number needed to treat in cardiovascular outcome trials of glucagon-like peptide-1 receptor agonists: A systematic review with temporal analysisMelanie J Davies, David E Kloecker, David R Webb, et al.
Annals of Internal Medicine|December 8, 2015
Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysisFrancesco Zaccardi, Zin Zin Htike, David R Webb, et al.
International Archives of Allergy and Immunology|June 25, 2021
lnterleukin-2 Stimulates the Development of Anergy via the Activation of Nonspecific Suppressor T CellsSatoshi Fukuse, Chigusa Terajima, Andrea Koontz, et al.
Pharmaceuticals (Basel, Switzerland)|December 2, 2020
Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?Ehtasham Ahmad, Jack A Sargeant, Francesco Zaccardi, et al.
Pageof 10

Showing results (21-30 of 96) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|November 4, 2022
Type 2 diabetesEhtasham Ahmad, Soo Lim, Roberta Lamptey, et al.
Plos One|June 5, 2008
Topical oestrogen keratinises the human foreskin and may help prevent HIV infectionAndrew J Pask, Kerry J McInnes, David R Webb, et al.
Diabetes Research and Clinical Practice|September 4, 2019
The right place for Sulphonylureas todayDavid R Webb, Melanie J Davies, Janet Jarvis, et al.
Clinical Immunology (Orlando, Fla.)|June 21, 2008
CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-betWeiming Xu, Maria Celeridad, Sabita Sankar, et al.
Diabetologia|May 3, 2018
Global burden of hypoglycaemia-related mortality in 109 countries, from 2000 to 2014: an analysis of death certificatesFrancesco Zaccardi, Nafeesa N Dhalwani, David R Webb, et al.
British Journal of Hospital Medicine (London, England : 2005)|February 28, 2006
Multi-resistant Escherichia coli sepsis following transrectal ultrasound-guided prostate biopsyAdee-Jonathan Davidson, David R Webb, Nathan Lawrentschuk, et al.
Diabetes, Obesity & Metabolism|May 7, 2020
Number needed to treat in cardiovascular outcome trials of glucagon-like peptide-1 receptor agonists: A systematic review with temporal analysisMelanie J Davies, David E Kloecker, David R Webb, et al.
Annals of Internal Medicine|December 8, 2015
Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments: A Systematic Review and Network Meta-analysisFrancesco Zaccardi, Zin Zin Htike, David R Webb, et al.
International Archives of Allergy and Immunology|June 25, 2021
lnterleukin-2 Stimulates the Development of Anergy via the Activation of Nonspecific Suppressor T CellsSatoshi Fukuse, Chigusa Terajima, Andrea Koontz, et al.
Pharmaceuticals (Basel, Switzerland)|December 2, 2020
Where Does Metformin Stand in Modern Day Management of Type 2 Diabetes?Ehtasham Ahmad, Jack A Sargeant, Francesco Zaccardi, et al.
Pageof 10